Related Experiment Video
Updated: Jul 21, 2025

Conformable Wearable Electrodes: From Fabrication to Electrophysiological Assessment
Published on: July 22, 2022
Wearable Insulin Biosensors for Diabetes Management: Advances and Challenges
Sotiria D Psoma1, Chryso Kanthou2
1School of Engineering & Innovation, The Open University, Milton Keynes MK7 6AA, UK.
Wearable insulin biosensors offer a promising alternative to traditional blood glucose monitoring for diabetes management. This review covers current advancements, future potential, and challenges in developing these essential devices.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Diabetes Technology
Background:
- Glucose biosensors have been vital in diabetes management for over 40 years.
- Current insulin detection methods are costly, time-consuming, and lack real-time monitoring.
- Wearable biosensors offer advantages like point-of-care testing, continuous monitoring, and miniaturization.
Purpose of the Study:
- To critically review the progress in wearable insulin biosensor technology.
- To assess current research, future developments, and challenges in the field.
- To highlight the potential of insulin biosensors for advanced diabetes management and personalized medicine.
Main Methods:
- Comprehensive literature review of current wearable insulin biosensor research.
- Analysis of different biosensor categories, including aptamer-based, MIP-based, and label-free.
- Assessment of technological advancements and challenges for commercialization.
Main Results:
- Wearable insulin biosensors are advancing, offering improved insulin sensitivity estimation and dosage regulation.
- Various biosensor types (aptamer, MIP, label-free) show significant potential.
- Development of a reliable artificial pancreas is a key long-term goal.
Conclusions:
- Wearable insulin biosensors are crucial for precise diabetes management and personalized medicine.
- Overcoming technical and commercialization challenges requires multidisciplinary collaboration.
- Continued innovation is needed for reliable, real-time monitoring wearable insulin biosensors.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

